tradingkey.logo
tradingkey.logo
検索

Evotec SE

EVO
ウォッチリストに追加
2.900USD
+0.050+1.75%
終値 07/02, 13:00ET15分遅れの株価
1.03B時価総額
損失額直近12ヶ月PER

詳細情報 Evotec SE 企業名

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Evotec SEの企業情報

企業コードEVO
会社名Evotec SE
上場日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)
従業員数4827
証券種類Depository Receipt
決算期末Oct 11
本社所在地Essener Bogen 7
都市HAMBURG
証券取引所NASDAQ OMX - NASDAQ BASIC
Germany
郵便番号22419
電話番号4940560810
ウェブサイトhttps://www.evotec.com/
企業コードEVO
上場日Oct 11, 1999
最高経営責任者「CEO」Wojczewski (Christian)

Evotec SEの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Laetitia Rouxel
Ms. Laetitia Rouxel
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mrs. Aurelie Dalbiez
Mrs. Aurelie Dalbiez
Chief People Officer, Member of the Management Board
Chief People Officer, Member of the Management Board
--
--
Dr. Christian Wojczewski
Dr. Christian Wojczewski
Chief Executive Officer, Member of the Management Board
Chief Executive Officer, Member of the Management Board
--
--
Dr. Duncan Mchale
Dr. Duncan Mchale
Member of the Supervisory Board
Member of the Supervisory Board
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Cord Dohrmann, Ph.D.
Dr. Cord Dohrmann, Ph.D.
Chief Scientific Officer, Member of the Management Board
Chief Scientific Officer, Member of the Management Board
--
--
Prof. Dr. Iris Loewfriedrich
Prof. Dr. Iris Loewfriedrich
Independent Chairwoman of the Supervisory Board
Independent Chairwoman of the Supervisory Board
--
--
Mr. Roland Sackers
Mr. Roland Sackers
Independent Vice Chairman of the Supervisory Board
Independent Vice Chairman of the Supervisory Board
--
--
Dr. Constanze Ulmer-Eilfort
Dr. Constanze Ulmer-Eilfort
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Volker Braun
Mr. Volker Braun
Senior Vice President, Head of Global Investor Relations and ESG
Senior Vice President, Head of Global Investor Relations and ESG
--
--
Ms. Camilla Macapili Languille
Ms. Camilla Macapili Languille
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--

よくある質問

Evotec SEの上位5名の株主は誰ですか?

Evotec SEの上位5名の株主は以下のとおりです。Dr. Cord Dohrmann, Ph.D.

Evotec SE(EVO)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Evotec SEの株式を保有している機関は81社あり、保有株式の総市場価値は約9.58Mで、全体の2.69%を占めています。2025Q4と比較して、機関の持ち株は-584606.00増加しています。